A strategy for producing predicted polymorphs: catemeric carbamazepine form V

被引：168

作者：

Arlin, Jean-Baptiste ^{[1
]}

Price, Louise S. ^{[2
]}

Price, Sarah L. ^{[2
]}

Florence, Alastair J. ^{[1
]}

机构：

[1] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Solid State Res Grp, Glasgow G4 0NR, Lanark, Scotland

[2] UCL, Dept Chem, London WC1H 0AJ, England

来源：

CHEMICAL COMMUNICATIONS | 2011年 / 47卷 / 25期

基金：

英国工程与自然科学研究理事会;

关键词：

CRYSTAL-STRUCTURES; PACKING MOTIFS; CRYSTALLIZATION;

D O I：

10.1039/c1cc11634g

中图分类号：

O6 [化学];

学科分类号：

0703 ;

摘要：

A computationally assisted approach has enabled the first catemeric polymorph of carbamazepine (form V) to be selectively formed by templating the growth of carbamazepine from the vapour phase onto the surface of a crystal of dihydrocarbamazepine form II.

引用

页码：7074 / 7076

页数：3

共 26 条

[1] A predicted dimer-based polymorph of 10,11-dihydrocarbamazepine (Form IV) [J].

Arlin, Jean-Baptiste ;

Johnston, Andrea ;

Miller, Gary J. ;

Kennedy, Alan R. ;

Price, Sarah L. ;

Florence, Alastair J. .

CRYSTENGCOMM, 2010, 12 (01) :64-66

[2] Cultivating crystal forms [J].

Bernstein, J .

CHEMICAL COMMUNICATIONS, 2005, (40) :5007-5012

[3] SOLID-STATE PHARMACEUTICAL CHEMISTRY [J].

BYRN, SR ;

PFEIFFER, RR ;

STEPHENSON, G ;

GRANT, DJW ;

GLEASON, WB .

CHEMISTRY OF MATERIALS, 1994, 6 (08) :1148-1158

[4] Screening strategies based on solubility and solution composition generate pharmaceutically acceptable cocrystals of carbamazepine [J].

Childs, Scott L. ;

Rodriguez-Hornedo, Nair ;

Reddy, L. Sreenivas ;

Jayasankar, Adivaraha ;

Maheshwari, Chinmay ;

McCausland, Linda ;

Shipplett, Rex ;

Stahly, Barbara C. .

CRYSTENGCOMM, 2008, 10 (07) :856-864

[5] Crystal engineering: A holistic view [J].

Desiraju, Gautam R. .

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2007, 46 (44) :8342-8356

[6] Exercises in prognostication: Crystal structures and protein folding [J].

Dunitz, JD ;

Scheraga, HA .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (40) :14309-14311

[7] Crystal engineering of the composition of pharmaceutical phases:: Multiple-component crystalline solids involving carbamazepine [J].

Fleischman, SG ;

Kuduva, SS ;

McMahon, JA ;

Moulton, B ;

Walsh, RDB ;

Rodríguez-Hornedo, N ;

Zaworotko, MJ .

CRYSTAL GROWTH & DESIGN, 2003, 3 (06) :909-919

[8] Two-dimensional similarity between forms I and II of cytenamide, a carbamazepine analogue [J].

Florence, A. J. ;

Bedford, C. T. ;

Fabbiani, F. P. A. ;

Shankland, K. ;

Gelbrich, T. ;

Hursthouse, M. B. ;

Shankland, N. ;

Johnston, A. ;

Fernandes, P. .

CRYSTENGCOMM, 2008, 10 (07) :811-813

[9] A catemer-to-dimer structural transformation in cyheptamide [J].

Florence, A. J. ;

Shankland, K. ;

Gelbrich, T. ;

Hursthouse, M. B. ;

Shankland, N. ;

Johnston, A. ;

Fernandes, P. ;

Leech, C. K. .

CRYSTENGCOMM, 2008, 10 (01) :26-28

[10] Control and prediction of packing motifs: a rare occurrence of carbamazepine in a catemeric configuration [J].

Florence, A. J. ;

Leech, C. K. ;

Shankland, N. ;

Shankland, K. ;

Johnston, A. .

CRYSTENGCOMM, 2006, 8 (10) :746-747

← 1 2 3 →